Navigation Links
Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2014
Date:8/3/2014

span>1,946Acquired intangible assets, net

24,34323,117

25,2364,102Deferred income tax assets

1,755-

--Other assets

3,46811,256

2,299374Total assets1,249,7041,158,072

1,290,701209,775LIABILITIES AND EQUITYCurrent liabilitiesShort-term borrowings

97,440205,000

285,00046,320Current portion of long-term borrowings

8,00016,500

21,5003,495Accounts payable

13,6914,590

13,0692,124Due to growers

7,60537,875

16,6652,709Due to related parties

16,7661,530

16,2302,638Advances from customers

337,382371,571

209,897'/>"/>

SOURCE Origin Agritech Limited
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Strange cousins: Molecular alternatives to DNA, RNA offer new insight into lifes origins
2. Origin Agritech Limited to Announce FY2012 Third Quarter Financial Results on August 7
3. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
4. The original Twitter? Tiny electronic tags monitor birds social networks
5. Origin Agritech Limited Reports Unaudited First Quarter Financial Results For Three Months Ended December 31, 2012
6. Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript
7. Human foot not as unique as originally thought
8. Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting
9. Hun School Bio Students Conduct Original Molecular Research in Conjunction with Rutgers University
10. TransCelerate BioPharma Inc. Launches Second Year Initiatives, Expands Membership and Achieves Milestones for Original Projects
11. BerGenBio Presents Data at AACR-ISLAC Conference on the Molecular Origins of Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:1/22/2015)... ALTO, Calif. , Jan. 22. 2015  Varian Medical Systems ... and software, has been honored for its commitment to sustainability ... sustainable companies. Varian is the highest ranked healthcare equipment company ... announced today during the World Economic Forum at ...
(Date:1/22/2015)... N.J. , Jan. 22, 2015  Derma Sciences, ... regeneration company focused on advanced wound care, announces ... placental tissues, have been added to the Premier, ... increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® ...
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ) ... ) has submitted a pre-market approval application to the ... of Medtronic,s SynchroMed ® II implantable drug infusion ... United Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... is part of Aeterna Zentaris, strategy of personalized approach to ... with doxorubicin, being investigated in multiple cancers , ... QUÉBEC CITY, ... Nasdaq: AEZS ), (the "Company"), a late-stage drug development ...
... ... enhance and treat cognition grew 31% in 2009, to $295M worldwide; and is forecasted to ... ... revenues for digital technologies to assess, enhance and treat cognition, or digital brain health ...
... ... of the Art 3D Dedicated Neurology Suite, , ... (PRWEB) June 28, 2010 -- TrueVision 3D Surgical announced ... Arizona to adopt TrueVision® 3D Surgical Visualization, where multiple 3D flat panel displays and ...
Cached Biology Technology:Aeterna Zentaris Announces Collaboration with Almac to Develop Therapy and Companion Diagnostic in Cancer 2Aeterna Zentaris Announces Collaboration with Almac to Develop Therapy and Companion Diagnostic in Cancer 3Aeterna Zentaris Announces Collaboration with Almac to Develop Therapy and Companion Diagnostic in Cancer 4New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 2New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 3New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 4New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research 5Cardon Children's Medical Center Adopts TrueVision 3D Surgical Visualization Platform for Department of Pediatric Neurosurgery 2
(Date:1/22/2015)... NEW YORK , Jan. 21, 2015  Analyst Report Issued ... Credit Card Brands report showed that planet-wide, transactions at merchants ... 2011, while the total number of credit, debit, and prepaid ... the U.S. were victims of fraudulent card usage in 2012, ...
(Date:12/24/2014)...  Since its launch in December 2014, the 1U™ ... of trying to remember their usernames and passwords through replacing ... smartphones. To assist people who have struggled to remember usernames ... 1U and focuses on redefining identity, announced today that it ...
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the addition ... Systems Market" report to their offering. ... security market is estimated to grow at a CAGR of ... a larger share in this market, Canada ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3
... from the Howard Hughes Medical Institute have succeeded in ... a wide range of odors, including vanilla, skunk, fish, ... overlapping ?patterns of neural activity represents a significant step ... odorant receptors in the nose into odor perception in ...
... an agency-wide initiative to speed development of new medical ... Drug Administration (FDA) today issued a final guidance titled ... to identify sources of an individual's profile of drug ... this individual. For example, genomic tests are helping to ...
... The chromosomes of mammals, including humans, contain regions that are ... cancer. Now, new research by geneticists at Duke University Medical ... in DNA and begins to reveal the molecular characteristics of ... findings, published in the March 11, 2005, issue of Cell, ...
Cached Biology News:Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer 2Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer 3Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer 4FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 2FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 3Insight into DNA's 'weakest links' may yield clues to cancer biology 2
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2) (67 kDa neutrophil oxidase factor) (p67-phox) (NOXA2). [Source:Uniprot/SWISSPROT;Acc:P19878] Antigen: Recombinant Protein E...
... to FANCM ( Abpromise for all ... Synthetic peptide derived from within residues 2000 ... (Note: the amino acid sequence is proprietary) ... ab27787 .) Entrez GeneID: ...
Biology Products: